BEAT — HeartBeam Inc · catalysts, narrative & risks

Overview (point-in-time, as of 2026-10-11)

HeartBeam, Inc. (NASDAQ: BEAT) is a Santa Clara–based medical technology company developing portable 3D ECG and 12-lead synthesis technologies for arrhythmia assessment and remote cardiac monitoring outside clinical settings [4], [21], [20]. As of Oct 9, 2026, the stock traded around $0.48 with a market cap of ~$27.06M, roughly 56.35M shares outstanding, and a 52-week range of $0.36–$4.00 [12], [17], [14]. It is a sub-$1 penny stock with heavy daily volume swings [12], [19].

Key Recent Catalysts (last ~1–3 months)